PA
TLSA icon

Parallel Advisors’s Tiziana Life Sciences TLSA Stock Holding History

Parallel Advisors’s Portfolio TLSA Stock Details TLSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-9,668
Closed -$9.28K – 3619
2024
Q3 		$9.28K Buy
+9,668
New +$9.77K ﹤0.01% 2419

Other funds holding TLSA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
ZF
Zhang Financial Portage, Michigan $3.42B AUM 23.04% 1-Year Est. Return
Kovitz Investment Group Partners
Kovitz Investment Group Partners Chicago, Illinois $4.31B AUM 20.41% 1-Year Est. Return
EL
EWA LLC Pittsbugh, Pennsylvania $548M AUM 35.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
BW
Bison Wealth Atlanta, Georgia $454M AUM 22.8% 1-Year Est. Return
GSC
Ground Swell Capital Folly Beach, South Carolina $50.7M AUM 30.19% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Parallel Advisors's TLSA Position: Q4 2024 in Review

Parallel Advisors sold out of Tiziana Life Sciences (TLSA) in Q4 2024, closing a stake of 9,668 shares — an estimated $9.28K sold.

Parallel Advisors first reported a position in TLSA in Q3 2024 and held it in 1 quarter. The position peaked at $9.28K in Q3 2024. 33 funds tracked by Wall St. Rank hold TLSA as of Q4 2024.

  • Parallel Advisors reported no remaining Tiziana Life Sciences position as of Q4 2024 after selling out during the quarter.
  • Parallel Advisors sold 9,668 Tiziana Life Sciences shares in Q4 2024, an estimated $9.28K.
  • Parallel Advisors first reported a position in Tiziana Life Sciences in Q3 2024 and held it in 1 quarter.
  • Parallel Advisors's Tiziana Life Sciences position peaked at $9.28K in Q3 2024.
  • 33 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q4 2024.

Based on Parallel Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.